Expert consensus on the prevention and treatment of anti cancer drug induced nausea and vomiting of Sichuan province (2024)_Chinese Journal of Evidence-Based Medicine

Authors：

 Sichuan Province Anti Cancer Drug Induced Nausea and Vomiting Experts Consensus Compilation Expert Group

Corresponding author：

Sichuan Province Anti Cancer Drug Induced Nausea and Vomiting Experts Consensus Compilation Expert Group, Email: zhujiang@wchscu.cn

Keywords：

Nausea; Vomiting; Anti cancer drug therapy; Consensus; Sichuan province

DOI：

10.7507/1672-2531.202407066

Video：

Export PDF Favorites Scan Get Citation

Abstract Full text Figures/Tables Video References Cited by

Nausea and vomiting are common side effects of anti cancer drug therapy, and significantly impact patient quality of life and treatment efficacy. Timely and effective prevention and management of these symptoms are crucial. In consideration of the healthcare situation in Sichuan province and relevant research findings, we have updated the "Expert consensus on the prevention and treatment of anti cancer drug induced nausea and vomiting of Sichuan province (2024)". This consensus aims to provide clinicians with professional advice and guidance tailored to the conditions in Sichuan province.

Citation： Sichuan Province Anti Cancer Drug Induced Nausea and Vomiting Experts Consensus Compilation Expert Group. Expert consensus on the prevention and treatment of anti cancer drug induced nausea and vomiting of Sichuan province (2024). Chinese Journal of Evidence-Based Medicine, 2024, 24(10): 1129-1136. doi: 10.7507/1672-2531.202407066 Copy

1.	Wiser W, Berger A. Practical management of chemotherapy-induced nausea and vomiting. Oncology (Williston Park), 2005, 19(5): 637-645.
2.	中国临床肿瘤学会指南工作委员会. 中国临床肿瘤学会(CSCO)抗肿瘤治疗相关恶心呕吐预防和治疗指南-2019. 北京: 人民卫生出版社, 2019.
3.	Li Y, Sun Y, Liu B, et al. Prolonged administration of aprepitant improves cisplatin-based chemotherapy-induced nausea and vomiting. Future Oncol, 2022, 18(20): 2533-2543.
4.	Li Y, Wan Y, Yang X, et al. Two doses of fosaprepitant included prophylactic treatment for the three-day cisplatin-based chemotherapy induced nausea and vomiting. J Cancer Res Clin Oncol, 2024, 150(6): 290.
5.	Wei H, Sun Y, Xie L, et al. Huo Xiang Zheng Qi oral liquid combined with 5-HT3 receptor antagonists and dexamethasone can prevent chemotherapy-induced nausea and vomiting for patients receiving multiday cisplatin-based regimen: a multicenter trial. J Integr Complement Med, 2023, 29(8): 501-509.
6.	Ezzo J, Vickers A, Richardson MA, et al. Acupuncture-point stimulation for chemotherapy-induced nausea and vomiting. J Clin Oncol, 2005, 23(28): 7188-7198.
7.	PDQ Integrative, Alternative, and Complementary Therapies Editorial Board. Topics in integrative, alternative, and complementary therapies (PDQ). Maryland State: National Cancer Institute (US), 2018.
8.	Wei H, Yue Z, Han J, et al. Oral compound probiotic supplements can improve the quality of life for patients with lung cancer during chemotherapy: a randomized placebo-controlled study. Thorac Cancer, 2024, 15(2): 182-191.
9.	Natale JJ. Overview of the prevention and management of CINV. Am J Manag Care, 2018, 24(18): S391-S397.
10.	Sun Y, Zheng Y, Yang X, et al. Incidence of chemotherapy-induced nausea and vomiting among cancer patients receiving moderately to highly emetogenic chemotherapy in cancer centers in Sichuan, China. J Cancer Res Clin Oncol, 2021, 147(9): 2701-2708.
11.	Tamura K, Aiba K, Saeki T, et al. Testing the effectiveness of antiemetic guidelines: results of a prospective registry by the CINV Study Group of Japan. Int J Clin Oncol, 2015, 20(5): 855-865.
12.	Grunberg S, Chua D, Maru A, et al. Single-dose fosaprepitant for the prevention of chemotherapy-induced nausea and vomiting associated with cisplatin therapy: randomized, double-blind study protocol-EASE. J Clin Oncol, 2011, 29(11): 1495-1501.
13.	方振威, 翟所迪. 阿瑞吡坦防治化疗致恶心呕吐的Meta分析. 北京大学学报(医学版), 2010, 42(6): 756-763.
14.	Grunberg SM, Rolski J, Strausz J, et al. Efficacy and safety of casopitant mesylate, a neurokinin 1 (NK1)-receptor antagonist, in prevention of chemotherapy-induced nausea and vomiting in patients receiving cisplatin-based highly emetogenic chemotherapy: a randomised, double-blind, placebo-controlled trial. Lancet Oncol, 2009, 10(6): 549-558.
15.	Powers D, Schnadig ID, Modiano MR, et al. Efficacy and safety of rolapitant for prevention of chemotherapy-induced nausea and vomiting (CINV) in patients (pts) receiving anthracycline-cyclophosphamide (AC)-based chemotherapy. J Clin Oncol, 2015, 33(29): 208.
16.	Jordan K, Kinitz I, Voigt W, et al. Safety and efficacy of a triple antiemetic combination with the NK-1 antagonist aprepitant in highly and moderately emetogenic multiple-day chemotherapy. Eur J Cancer, 2009, 45(7): 1184-1187.
17.	Hu Z, Cheng Y, Zhang H, et al. Aprepitant triple therapy for the prevention of chemotherapy-induced nausea and vomiting following high-dose cisplatin in Chinese patients: a randomized, double-blind, placebo-controlled phase Ⅲ trial. Support Care Cancer, 2014, 22(4): 979-987.
18.	Gupta N, Hatoum H, Ustwani O, et al. 721: Aprepitant combinations (AC) for chemotherapy-induced nausea and vomiting (CINV) in adults: a meta-analysis of randomized controlled trials (RCTs). Eur J Cancer, 2014, 50(Suppl 5): S173.
19.	Navari RM, Qin R, Ruddy KJ, et al. Olanzapine for the prevention of chemotherapy-induced nausea and vomiting. N Engl J Med, 2016, 375(2): 134-142.
20.	Di Mattei VE, Carnelli L, Carrara L, et al. Chemotherapy-induced nausea and vomiting in women with gynecological cancer: a preliminary single-center study investigating medical and psychosocial risk factors. Cancer Nurs, 2016, 39(6): E52-E59.
21.	Luo X, Yang L, Chen J, et al. Chemotherapy induced nausea and vomiting may cause anxiety and depression in the family caregivers of patients with cancer. Front Psychiatry, 2023, 14: 1221262.
22.	Lvarez YE, Carpeo JDC, Bell D, et al. Prevention of chemotherapy-induced nausea and vomiting in the real-world setting in Spain. Clin Transl Oncol, 2021, (1): 1-8.

1. Wiser W, Berger A. Practical management of chemotherapy-induced nausea and vomiting. Oncology (Williston Park), 2005, 19(5): 637-645.
2. 中国临床肿瘤学会指南工作委员会. 中国临床肿瘤学会(CSCO)抗肿瘤治疗相关恶心呕吐预防和治疗指南-2019. 北京: 人民卫生出版社, 2019.
3. Li Y, Sun Y, Liu B, et al. Prolonged administration of aprepitant improves cisplatin-based chemotherapy-induced nausea and vomiting. Future Oncol, 2022, 18(20): 2533-2543.
4. Li Y, Wan Y, Yang X, et al. Two doses of fosaprepitant included prophylactic treatment for the three-day cisplatin-based chemotherapy induced nausea and vomiting. J Cancer Res Clin Oncol, 2024, 150(6): 290.
5. Wei H, Sun Y, Xie L, et al. Huo Xiang Zheng Qi oral liquid combined with 5-HT3 receptor antagonists and dexamethasone can prevent chemotherapy-induced nausea and vomiting for patients receiving multiday cisplatin-based regimen: a multicenter trial. J Integr Complement Med, 2023, 29(8): 501-509.
6. Ezzo J, Vickers A, Richardson MA, et al. Acupuncture-point stimulation for chemotherapy-induced nausea and vomiting. J Clin Oncol, 2005, 23(28): 7188-7198.
7. PDQ Integrative, Alternative, and Complementary Therapies Editorial Board. Topics in integrative, alternative, and complementary therapies (PDQ). Maryland State: National Cancer Institute (US), 2018.
8. Wei H, Yue Z, Han J, et al. Oral compound probiotic supplements can improve the quality of life for patients with lung cancer during chemotherapy: a randomized placebo-controlled study. Thorac Cancer, 2024, 15(2): 182-191.
9. Natale JJ. Overview of the prevention and management of CINV. Am J Manag Care, 2018, 24(18): S391-S397.
10. Sun Y, Zheng Y, Yang X, et al. Incidence of chemotherapy-induced nausea and vomiting among cancer patients receiving moderately to highly emetogenic chemotherapy in cancer centers in Sichuan, China. J Cancer Res Clin Oncol, 2021, 147(9): 2701-2708.
11. Tamura K, Aiba K, Saeki T, et al. Testing the effectiveness of antiemetic guidelines: results of a prospective registry by the CINV Study Group of Japan. Int J Clin Oncol, 2015, 20(5): 855-865.
12. Grunberg S, Chua D, Maru A, et al. Single-dose fosaprepitant for the prevention of chemotherapy-induced nausea and vomiting associated with cisplatin therapy: randomized, double-blind study protocol-EASE. J Clin Oncol, 2011, 29(11): 1495-1501.
13. 方振威, 翟所迪. 阿瑞吡坦防治化疗致恶心呕吐的Meta分析. 北京大学学报(医学版), 2010, 42(6): 756-763.
14. Grunberg SM, Rolski J, Strausz J, et al. Efficacy and safety of casopitant mesylate, a neurokinin 1 (NK1)-receptor antagonist, in prevention of chemotherapy-induced nausea and vomiting in patients receiving cisplatin-based highly emetogenic chemotherapy: a randomised, double-blind, placebo-controlled trial. Lancet Oncol, 2009, 10(6): 549-558.
15. Powers D, Schnadig ID, Modiano MR, et al. Efficacy and safety of rolapitant for prevention of chemotherapy-induced nausea and vomiting (CINV) in patients (pts) receiving anthracycline-cyclophosphamide (AC)-based chemotherapy. J Clin Oncol, 2015, 33(29): 208.
16. Jordan K, Kinitz I, Voigt W, et al. Safety and efficacy of a triple antiemetic combination with the NK-1 antagonist aprepitant in highly and moderately emetogenic multiple-day chemotherapy. Eur J Cancer, 2009, 45(7): 1184-1187.
17. Hu Z, Cheng Y, Zhang H, et al. Aprepitant triple therapy for the prevention of chemotherapy-induced nausea and vomiting following high-dose cisplatin in Chinese patients: a randomized, double-blind, placebo-controlled phase Ⅲ trial. Support Care Cancer, 2014, 22(4): 979-987.
18. Gupta N, Hatoum H, Ustwani O, et al. 721: Aprepitant combinations (AC) for chemotherapy-induced nausea and vomiting (CINV) in adults: a meta-analysis of randomized controlled trials (RCTs). Eur J Cancer, 2014, 50(Suppl 5): S173.
19. Navari RM, Qin R, Ruddy KJ, et al. Olanzapine for the prevention of chemotherapy-induced nausea and vomiting. N Engl J Med, 2016, 375(2): 134-142.
20. Di Mattei VE, Carnelli L, Carrara L, et al. Chemotherapy-induced nausea and vomiting in women with gynecological cancer: a preliminary single-center study investigating medical and psychosocial risk factors. Cancer Nurs, 2016, 39(6): E52-E59.
21. Luo X, Yang L, Chen J, et al. Chemotherapy induced nausea and vomiting may cause anxiety and depression in the family caregivers of patients with cancer. Front Psychiatry, 2023, 14: 1221262.
22. Lvarez YE, Carpeo JDC, Bell D, et al. Prevention of chemotherapy-induced nausea and vomiting in the real-world setting in Spain. Clin Transl Oncol, 2021, (1): 1-8.

Previous Article
Clinical practice guidelines of calcium for prevention of primary osteoporosis in adults
Next Article
Chinese expert consensus on skeletal muscle aging biomarkers (2024): a protocol

Chinese Journal of Evidence-Based Medicine

Expert consensus on the prevention and treatment of anti cancer drug induced nausea and vomiting of Sichuan province (2024)

Abstract Full text Figures/Tables Video References Cited by

Previous Article

Next Article

Format

Content